Rami Doukky to Adult
This is a "connection" page, showing publications Rami Doukky has written about Adult.
Connection Strength
0.728
-
The prognostic utility of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease: The largest cohort to date. J Nucl Cardiol. 2022 Feb; 29(1):101-110.
Score: 0.071
-
Utilization Effects of the Affordable Care Act on Implantable Cardioverter-Defibrillator Therapy. J Am Coll Cardiol. 2020 04 14; 75(14):1714-1717.
Score: 0.070
-
The diagnostic and prognostic utility of risk factors defined by the AHA/ACCF on the evaluation of cardiac disease in liver transplantation candidates. BMC Cardiovasc Disord. 2019 05 02; 19(1):102.
Score: 0.066
-
Clinical predictors and outcomes of patients with pericardial effusion in chronic kidney disease. Clin Cardiol. 2018 May; 41(5):660-665.
Score: 0.061
-
The significance of post-stress decrease in left ventricular ejection fraction in patients undergoing regadenoson stress gated SPECT myocardial perfusion imaging. J Nucl Cardiol. 2018 08; 25(4):1313-1323.
Score: 0.056
-
Impact of Appropriate Use on the Estimated Radiation Risk to Men and Women Undergoing Radionuclide Myocardial Perfusion Imaging. J Nucl Med. 2016 Aug; 57(8):1251-7.
Score: 0.053
-
Impact of insurance carrier, prior authorization, and socioeconomic status on appropriate use of SPECT myocardial perfusion imaging in private community-based office practice. Clin Cardiol. 2015 May; 38(5):267-73.
Score: 0.050
-
Prognostic implications of stress modality on mortality risk and cause of death in patients undergoing office-based SPECT myocardial perfusion imaging. J Nucl Cardiol. 2016 Apr; 23(2):202-11.
Score: 0.049
-
The prognostic value of undetectable highly sensitive cardiac troponin I in patients with acute pulmonary embolism. Chest. 2015 Mar; 147(3):685-694.
Score: 0.049
-
Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials. J Nucl Cardiol. 2015 Oct; 22(5):1008-18.
Score: 0.049
-
Rheumatic heart disease in modern urban America: a cohort study of immigrant and indigenous patients in Chicago. Int J Cardiol. 2014 Jul 15; 175(1):178-80.
Score: 0.046
-
Attenuation of the side effect profile of regadenoson: a randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease--the ASSUAGE-CKD trial. Int J Cardiovasc Imaging. 2013 Jun; 29(5):1029-37.
Score: 0.042
-
Soft tissue attenuation patterns in stress myocardial perfusion SPECT images: a comparison between supine and upright acquisition systems. J Nucl Cardiol. 2011 Apr; 18(2):281-90.
Score: 0.037
-
Elderly Medication Adherence Intervention Using the My Interventional Drug-Eluting Stent Educational App: Multisite Randomized Feasibility Trial. JMIR Mhealth Uhealth. 2020 06 24; 8(6):e15900.
Score: 0.018
-
Predictors of diastolic dysfunction among minority patients with newly diagnosed type 2 diabetes. Diabetes Res Clin Pract. 2010 May; 88(2):189-95.
Score: 0.009